Compound ID | 1713
Class: SrtA inhibitor
| Spectrum of activity: | Gram-positive |
| Details of activity: | Interferes with the adhesion of Staphylococcal aureus |
| Institute where first reported: | Kyoto Pharmaceutical University, Japan |
| Year first mentioned: | 1996 |
| Highest developmental phase: | Preclinical |
| Chemical structure(s): | |||||||||||
|
|